Kidecar, there are many folks out there that invest and are not privy to information that helps determine risk. MDAS executives count on this lack of transparency for their own benefit. The character of folks that run the company is a big indicator as to the opportunity for long term growth that will benefit everyone involved. IMO, MDAS is sorely lacking in this area. No reason to take my word for it, as it is a matter of public record. In 2007 the IPO was $16, and the current price 5 years later is roughly the same. Now that would certainly be understandable if there was a split or two along the way, but that did not happen. To refresh everyone's memory, in 2010 MDAS told the investor public that the late stage pipeline was 50% larger than the prior year. In Q4, they missed their guidance and $400M+ was lost in market cap. IMO, when you intentionally mislead then you can't be trusted in the future without purging the folks that were responsible. The old adage "fool me once shame on you, fool me twice shame on me"!
Nearly 5 years after going public, and the stock price is below IPO. Tell the "whole new ball game" story to the folks who relied on executive released mdas info in 2010. IMO, It is only a matter of time until the unethical nature of this leadership team strikes again. They are rotten to the core.
We will need to go above 14 and build a base @ 14+ before worrying about a 52-week high.
I am still waiting to hear about cross-platform data access (or at a minimum consolidated reporting). I think THAT will be the catalyst that drives this company. Several big purchases were made (Xactimed, Accuro, Broadlane), each of which has different database schemas. To demonstrate that they can be melded into a common data repository would ignite this company.
Some on this MB think that is is a pipe dream due to lack of talent or resources or commitment or it is just technologically unrealistic. I think that it is very possible and technically obtainable goal. Maybe we will get some hint of new development in the CC.
Until then, MDAS is still performing MUCH better than the general market YTD